In Vivo Study of THC-induced Immune-genome Changes at Single Cell Solution in HIV-infected Humans

Clinical trial NCT04920539 · COMPLETED

Trial details

NCT number: NCT04920539
Sponsor: Yale University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HIV Infections Healthy

Start date: 2022-02-08
Primary completion: 2025-12-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.